from Reuters: U.S. https://ift.tt/2ItvspY
Friday, 22 February 2019
Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke
Catalyst Pharmaceuticals Inc, rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its $375,000 treatment for a rare disease, saying the price was in line with similar products in the industry.
from Reuters: U.S. https://ift.tt/2ItvspY
from Reuters: U.S. https://ift.tt/2ItvspY
Related Posts:
Ex-officer charged in beating of man at New York homeless shelter- Senator McSally, an Air Force veteran, says she was raped by a superior officer
- Don't expect details from Mueller probe: senior U.S. Republican
- Wisconsin man jailed for kidnap-murder confesses in letter -report
- Illinois shooting victim sues state police over gun buy: report
0 comments:
Post a Comment